Michel Burnier

Publications | Mémoires et thèses

La recherche avancée est accessible via Serval

Les publications peuvent être gérées en accédant à Serval via MyUnil


907 publications

... | 1997 | 1996 | 1995 | 1994 | 1993 | 1992 | 1991 | 1990 | 1989 | 1988 | 1987 | 1986 | 1985 | 1983 | 1982 | 1981 |
1997
 
Facteurs endotheliaux et insuffisance cardiaque. [Endothelial factors and cardiac insufficiency]
Burnier M., 1997/02. Schweizerische Rundschau fur Medizin Praxis, 86 (7) pp. 242-5.
[Pmid][serval:BIB_A00EBA160749]
 
Heterogeneous vascular response to vasopressin: radial artery versus forearm blood flow
Hayoz D., Weber R., Pechere A., Burnier M., Brunner H. R., 1997/01. Journal of Hypertension, 15 (1) pp. 35-41.
[WoS][Pmid][serval:BIB_5D656D3968E0]
 
Urgences hypertensives
De Torrenté A., Burnier M., 1997. pp. 300-306 dans A. Restellini , P. J. Malé , P. F. Unger , M. A. Raetzo (eds.) Urgences Médicales, Médecine et Hygiène.
[serval:BIB_AED1D0CD10A8]
1996
 
Le diagnostic et le traitement de l'hypertension artérielle chez la personne âgée [Diagnosis and treatment of arterial hypertension in the elderly]
Waeber B., Pechere A., Burnier M., Brunner H.R., 1996/02. Praxis, 85 (6) pp. 150-4.
[Pmid][serval:BIB_CAE6B8284293]
 
Cytosolic and nuclear calcium imaging by confocal microscopy
Burnier M., Centeno G, Brunner H.H., 1996. pp. 319-328 dans M.D. Maines (eds.) Nitric Oxide Synthase. Characterization and functional analysis a volume of Methods in Neuroscience, Academic Press Inc.
[serval:BIB_C101BF6A758F]
 
Determination of trace lithium in biological fluids using graphite furnace atomic absorption spectrophotometry: variability of urine matrices circumvented by cation exchange solid phase extraction.
Magnin J.L., Decosterd L.A., Centeno C., Burnier M., Diezi J., Biollaz J., 1996. Pharmaceutica acta Helvetiae, 71 (4) pp. 237-246. Peer-reviewed.
[Pmid][serval:BIB_1322CA2919AC]
 
Experience with angiotensin II antagonists in hypertensive patients.
Waeber B., Burnier M., Nussberger J., Brunner H.R., 1996. Clinical and experimental pharmacology & physiology. Supplement, 3 pp. S142-6.
[Pmid][serval:BIB_CE4479240949]
 
Isolated office hypertension: a prehypertensive state?
Bidlingmeyer I., Burnier M., Bidlingmeyer M., Waeber B., Brunner H.R., 1996. Journal of hypertension, 14 (3) pp. 327-332. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_3B6B757E8274]
 
Pharmacokinetic-pharmacodynamic relationships of three angiotensin II receptor antagonists in normal volunteers.
Burnier M., Buclin T., Biollaz J., Nussberger J., Waeber B., Brunner H.R., 1996. Kidney international. Supplement, 55 pp. S24-9.
[Pmid][serval:BIB_05B71016731F]
 
Renal effects of angiotensin II receptor blockade and angiotensin-converting enzyme inhibition in healthy subjects
Burnier M., Brunner H. R., 1996. Experimental Nephrology, 4 Suppl 1 pp. 41-6.
[WoS][Pmid][serval:BIB_899111ED6517]
1995
 
Renal haemodynamic and protective effects of calcium antagonists in hypertension
Zanchi A., Brunner H. R., Waeber B., Burnier M., 1995/12. Journal of Hypertension, 13 (12 Pt 1) pp. 1363-75. Peer-reviewed.
[Pmid][serval:BIB_901C61C54A2F]
 
Diagnostic et traitement des urgences hypertensives. [Diagnosis and treatment of hypertensive emergencies]
Burnier M., Waeber B., Brunner H. R., 1995/11. Schweizerische Medizinische Wochenschrift, 125 (47) pp. 2261-6.
[WoS][Pmid][serval:BIB_2839C60C3691]
 
Renin secretion: the difficulty of extrapolating from in vitro to in vivo studies.
Waeber B., Burnier M., 1995/11. European Journal of Endocrinology, 133 (5) p. 523. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_0FB041E42507]
 
Faut-il former tous les médecins de premier recours à l'ultrasonographie? Enquête chez les praticiens. Groupe de Praticiens PMU. [Should all primary care physicians be educated in ultrasonography? Survey among practitioners. Group of Practitioners of the University Medical Polyclinic]
Verdon F., Decrey H., Burnand B., Burnier M., Pecoud A., 1995/08. Revue médicale de la Suisse Romande, 115 (8) pp. 595-7.
[Pmid][serval:BIB_BFFCBA99ED97]
 
Differential nitric oxide synthase activity in human platelets during normal pregnancy and pre-eclampsia.
Delacrétaz E., de Quay N., Waeber B., Vial Y., Schulz P.E., Burnier M., Brunner H.R., Bossart H., Schaad N.C., 1995/06. Clinical Science, 88 (6) pp. 607-610. Peer-reviewed.
[WoS][Pmid][serval:BIB_8A71038D4654]
 
Clinical pharmacology of the angiotensin II receptor antagonist losartan potassium in healthy subjects
Burnier M., Waeber B., Brunner H. R., 1995. Journal of Hypertension. Supplement, 13 (1) pp. S23-8.
[DOI][WoS][Pmid][serval:BIB_C819EAA2F2A1]
 
Douleurs cervicales et thoraciques inhabituelles chez deux jeunes patients [Unusual cervical and thoracic pain in 2 young patients]
Favrat B., Burnier M., Cornuz J., Zellweger J.P., 1995. Revue médicale de la Suisse romande, 115 (8) pp. 591-3.
[Pmid][serval:BIB_A675C5E31CA6]
 
Effect of endotoxin on the angiotensin II receptor in cultured vascular smooth muscle cells.
Burnier M., Centeno G., Waeber G., Centeno C., Bürki E., 1995. British journal of pharmacology, 116 (5) pp. 2524-30. Peer-reviewed.
[WoS][Pmid][serval:BIB_36E336EBC670]
 
Improvement of renal failure with repeated head-out water immersions in patients with hepatorenal syndrome associated with alcoholic hepatitis.
Yersin B., Burnier M., Magnenat P., 1995. American Journal of Nephrology, 15 (3) pp. 260-265.
[DOI][WoS][Pmid][serval:BIB_EF3CA34DE845]
 
L'approche de l'homéostasie du sodium par le dosage du lithium trace
Pechère-Bertschi A., Burnier M., Biollaz J., 1995. Médecine et Hygiène, 53 (2063) pp. 582-584.
[serval:BIB_F1D0DBD9A1F7]
 
L'urgence et la crise hypertensive: définition et traitement [Emergency and hypertensive crisis: definition and treatment]
Waeber B., Burnier M., Brunner H.R., 1995. Praxis, 84 (45) pp. 1292-1295.
[Pmid][serval:BIB_6E6563FE5A9E]
 
Neutral endopeptidase versus angiotensin converting enzyme inhibition in essential hypertension.
Favrat B., Burnier M., Nussberger J., Lecomte J.M., Brouard R., Waeber B., Brunner H.R., 1995. Journal of hypertension, 13 (7) pp. 797-804. Peer-reviewed.
[WoS][Pmid][serval:BIB_886CECFB8366]
 
Postischemic blood flow response in hypercholesterolemic patients.
Hayoz D., Weber R., Rutschmann B., Darioli R., Burnier M., Waeber B., Brunner H.R., 1995. Hypertension, 26 (3) pp. 497-502. Peer-reviewed.
[WoS][Pmid][serval:BIB_4B0421F89971]
 
Screening for excessive alcohol drinking. Comparative value of carbohydrate-deficient transferrin, gamma-glutamyltransferase, and mean corpuscular volume.
Yersin B., Nicolet J.F., Dercrey H., Burnier M., van Melle G., Pécoud A., 1995. Archives of Internal Medicine, 155 (17) pp. 1907-1911.
[DOI][WoS][Pmid][serval:BIB_CC09B99E43CE]
 
Short-term and sustained renal effects of angiotensin II receptor blockade in healthy subjects.
Burnier M., Hagman M., Nussberger J., Biollaz J., Armagnac C., Brouard R., Weber B., Brunner H.R., 1995. Hypertension, 25 (4 Pt 1) pp. 602-609. Peer-reviewed.
[WoS][Pmid][serval:BIB_92E0E77EFAC3]
 
Studies of the renal effects of angiotensin II receptor blockade: the confounding factor of acute water loading on the action of vasoactive systems.
Burnier M., Pechère-Bertschi A., Nussberger J., Waeber B., Brunner H.R., 1995. American Journal of Kidney Diseases, 26 (1) pp. 108-115. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_9252870BB9BF]
1994
 
Angiotensin II receptor antagonists and the kidney
Burnier M., Brunner H. R., 1994/09. Current Opinion in Nephrology and Hypertension, 3 (5) pp. 537-45.
[Pmid][serval:BIB_7176DBF4C46B]
 
A device for subjecting vascular endothelial cells to both fluid shear stress and circumferential cyclic stretch
Moore, J. E., Jr. , Burki E., Suciu A., Zhao S., Burnier M., Brunner H. R., Meister J. J., 1994/08. Annals of Biomedical Engineering, 22 (4) pp. 416-22.
[DOI][WoS][Pmid][serval:BIB_B0C735560E02]
 
The advantages of angiotensin II antagonism
Burnier M., Waeber B., Brunner H. R., 1994/07. Journal of Hypertension. Supplement, 12 (2) pp. S7-15.
[WoS][Pmid][serval:BIB_8CC1E312BB63]
 
Confocal microscopy to analyze cytosolic and nuclear calcium in cultured vascular cells
Burnier M., Centeno G., Burki E., Brunner H. R., 1994/04. American Journal of Physiology. Cell Physiology, 266 (4 Pt 1) pp. C1118-27.
[WoS][Pmid][serval:BIB_F4F4BDAA5429]
 
Renal sodium handling in patients with untreated hypertension and white coat hypertension
Burnier M., Biollaz J., Magnin J. L., Bidlingmeyer M., Brunner H. R., 1994/04. Hypertension, 23 (4) pp. 496-502.
[WoS][Pmid][serval:BIB_20D4AF2378A6]
 
Age-dependent drug prescription in a general intrenal medicine university out-patients' departement
Rouge C., Fallab C. L., Burnier M., 1994. pp. 45-49 dans G. L. Zelger , C. Surber , S. Marty , E. Doelker , M. Tully (eds.) Drug Treatment in the Elderly, European Society of Clinical Pharmacy.
[serval:BIB_B2EFFF9C97BA]
 
Angiotensin II antagonists DuP 753 and TCV 116.
Brunner H.R., Delacrétaz E., Nussberger J., Burnier M., Waeber B., 1994. Journal of Hypertension. Supplement, 12 (9) pp. S29-34.
[WoS][Pmid][serval:BIB_6DD65AD72B24]
 
Angiotensin-II mediates norepinephrine and neuropeptide-Y secretion in a human pheochromocytoma.
Grouzmann E., Werffeli-George P., Fathi M., Burnier M., Waeber B., Waeber G., 1994. Journal of Clinical Endocrinology and Metabolism, 79 (6) pp. 1852-1856. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_9EFF36B0225E]
 
Clinical application of treatment with angiotensin receptor antagonists
Burnier M., Waeber B., Brunner H. R., 1994. pp. 363-376 dans J. M. Saavedra , P. B. M. W. Timmermans (eds.) Angioensin Receptors, Plenum Press.
[serval:BIB_7A41B554AE26]
 
Clinical utility of ambulatory blood pressure monitoring in the evaluation of patients with borderline hypertension.
Waeber B., Burnier M., Heynen G., Brunner H.R., 1994. Journal of cardiovascular risk, 1 (2) pp. 120-126. Peer-reviewed.
[Pmid][serval:BIB_6B920DCEFDBD]
 
Experiences en cours dans l'enseignement de la "medecine generale". [Experiences in the course of teaching "general medicine"]
Pecoud A., Burnier M., 1994/01. Revue Médicale de la Suisse Romande, 114 (1) pp. 75-7.
[Pmid][serval:BIB_5CA6BC8F4CB3]
 
Fractional excretion of trace lithium and uric acid in acute renal failure.
Steinhäuslin F., Burnier M., Magnin J.L., Munafo A., Buclin T., Diezi J., Biollaz J., 1994. Journal of the American Society of Nephrology, 4 (7) pp. 1429-1437. Peer-reviewed.
[WoS][Pmid][serval:BIB_13ED9FB344A2]
 
Les désordres de la balance de l'eau
Burnier M., Waeber B., Biollaz J., Brunner H.R., 1994. pp. 51-61 dans Le métabolisme électrolytique et minéral, Médecine et Hygiène.
[serval:BIB_6CEF30E41401]
 
Localization of neuropeptide Y and its C-terminal flanking peptide in human renal tissue
Grouzmann E., Alvarez-Bolado G., Meyer C., Osterheld M. C., Burnier M., Brunner H. R., Waeber B., 1994. Peptides, 15 (8) pp. 1377-82.
[DOI][WoS][Pmid][serval:BIB_86FB96CF5736]
 
Mechanisms of the pressor response to intravenous thyrotropin-releasing hormone in the rat.
Evequoz D., Burnier M., Niederberger M., Brunner H.R., Nussberger J., Waeber B., 1994. Clinical and experimental pharmacology & physiology, 21 (2) pp. 93-100. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_2A88CB2BFA79]
 
The inhibition of the renin-angiotensin system as a therapeutic modality
Waeber B., Burnier M., Brunner H. R., 1994. pp. 27-46 dans P. B. M. W. Timmermans , R. R. Wexler (eds.) Medical Chemistry of the Renin Angiotensin System, Elsevier Science B.V..
[serval:BIB_FB263CF625D2]
1993
 
Diabète et insuffisance rénale terminale: constat d'échec ou réflexion sur la fonction soignante? [Diabetes and terminal renal insufficiency: statement of failure or reflection on the caregiving function?]
Vannotti M., Burnier M., 1993/09. Revue Médicale de la Suisse Romande, 113 (9) pp. 711-714.
[Pmid][serval:BIB_B9BE98E0AC46]
 
Short time exposure to lipopolysaccharide is sufficient to activate human monocytes.
Gallay P., Jongeneel C.V., Barras C., Burnier M., Baumgartner J.D., Glauser M.P., Heumann D., 1993/06. Journal of Immunology, 150 (11) pp. 5086-5093.
[WoS][Pmid][serval:BIB_97E99BC52DEA]
 
Angiotensin II antagonists.
Brunner H.R., Nussberger J., Burnier M., Waeber B., 1993. Clinical and experimental hypertension, 15 (6) pp. 1221-38. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_DB863DBD7E56]
 
Angiotensin-converting enzyme inhibitors in the treatment of hypertension
Waeber B., Burnier M., Brunner H. R., 1993. pp. 909-930 dans B. N. Singh , V. J. Dzau , P. M. Vanhoutte , R. L. Woosley (eds.) Cardiovascular Pharmacology and Therapeutics, Churchill Livingstone.
[serval:BIB_5592087350A9]
 
Mediators in septic schock: the renin-angiotensin system
Burnier M., Burki E., Waeber B., Brunner H. R., 1993. pp. 259-269 dans E. A. Neugebauer , J. W. Holaday (eds.) Handbook of Mediators in septic shock, CRC Press.
[serval:BIB_BA0010651A2B]
 
Role of neuropeptideY in endotoxemia
Burki E., Burnier M., Waeber B., Brunner H. R., 1993. pp. 271-277 dans E. A. Neugebauer , J. W. Holaday (eds.) Handbook of Mediators in septic shock, CRC Press.
[serval:BIB_2321C85D74C5]
 
Salt-dependent renal effects of an angiotensin II antagonist in healthy subjects.
Burnier M., Rutschmann B., Nussberger J., Versaggi J., Shahinfar S., Waeber B., Brunner H.R., 1993. Hypertension, 22 (3) pp. 339-47. Peer-reviewed.
[WoS][Pmid][serval:BIB_AEA9226E17BD]
1992
 
Neurohormonal consequences of diuretics in different cardiovascular syndromes
Burnier M., Brunner H. R., 1992/12. European Heart Journal, 13 Suppl G pp. 28-33.
[WoS][Pmid][serval:BIB_25A92BFAAB1B]
 
First-line pharmacological treatment of hypertension
Burnier M., Waeber B., Brunner H. R., 1992/11. Journal of Internal Medicine, 232 (5) pp. 381-8.
[DOI][WoS][Pmid][serval:BIB_FE9DD9A83024]
 
Migration of centromere proteins in rabbit spermatids
Courtens J. L., Biggiogera M., Rothfield N. F., Burnier M., Fakan S., 1992/08. Molecular Reproduction and Development, 32 (4) pp. 369-77.
[DOI][WoS][Pmid][serval:BIB_25595711A314]
 
Production and characterization of four anti-neuropeptide Y monoclonal antibodies
Grouzmann E., Comoy E., Walker P., Burnier M., Bohuon C., Waeber B., Brunner H., 1992/08. Hybridoma, 11 (4) pp. 409-24.
[DOI][WoS][Pmid][serval:BIB_E31065477959]
 
Pharmacokinetic optimisation of angiotensin converting enzyme (ACE) inhibitor therapy
Burnier M., Biollaz J., 1992/05. Clinical Pharmacokinetics, 22 (5) pp. 375-84.
[DOI][WoS][Pmid][serval:BIB_FF2E8ECA1A8A]
 
Time-dependent protective effects of calcium channel blockers on anoxia- and hypoxia-induced proximal tubule injury
Almeida A. R., Bunnachak D., Burnier M., Wetzels J. F., Burke T. J., Schrier R. W., 1992/02. Journal of Pharmacology and Experimental Therapeutics, 260 (2) pp. 526-32.
[WoS][Pmid][serval:BIB_6E56FAF76F79]
 
Le traitement de l'hypertension artérielle: quel médicament pour quelle malade [The treatment of arterial hypertension: which drug for which patient?]
Wafber B., Niederberger M., Nussberger J., Burnier M., Brunner H.R., 1992. Schweizerische Rundschau für Medizin Praxis, 81 (3) pp. 32-36.
[Pmid][serval:BIB_8DFA732B7EAF]
 
Renovascular and Renal Parenchymatous Hypertension
Burnier M., Waeber B., Nussberger J., Brunner H. R., 1992. pp. 336-349 dans T. F. Luscher , N. M. Kaplan (eds.) Medical Therapy in Renovascular Hypertension: Angiotensin-Converting Enzyme Inhibitors, Springer Verlag.
[serval:BIB_A91258D2802E]
1991
 
Antihypertensive therapy and mobilization of renal functional reserve
Burnier M., Biollaz J., Steinhauslin F., Brouard R., Waeber B., Brunner H. R., 1991/12. Clinical and Investigative Medicine, 14 (6) pp. 581-9.
[WoS][Pmid][serval:BIB_8F65F93582BE]
 
Signification d'une proteinurie. [The significance of proteinuria]
Burnier M., Bidlingmeyer M., 1991/07. Revue Médicale de la Suisse Romande, 111 (7) pp. 577-82.
[Pmid][serval:BIB_A7258C8011E8]
 
In vitro effects of DuP 753, a nonpeptide angiotensin II receptor antagonist, on human platelets and rat vascular smooth muscle cells
Burnier M., Centeno G., Grouzmann E., Walker P., Waeber B., Brunner H. R., 1991/05. American Journal of Hypertension, 4 (5 Pt 1) pp. 438-43.
[WoS][Pmid][serval:BIB_65218E53ABF4]
 
L'insuffisance cardiaque: comment la traiter? [Cardiac insufficiency: how can we treat it?]
Burnier M., Waeber B., Brunner H. R., 1991/05. Revue Médicale de la Suisse Romande, 111 (5) p. 425.
[Pmid][serval:BIB_F0833F433014]
 
The role of neuropeptide Y in cardiovascular regulation.
Walker P., Grouzmann E., Burnier M., Waeber B., 1991/03. Trends in Pharmacological Sciences, 12 (3) pp. 111-115. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_EC2079673D0F]
 
Effects of SCH 34826, an orally active inhibitor of atrial natriuretic peptide degradation, in healthy volunteers.
Burnier M., Ganslmayer M., Perret F., Porchet M., Kosoglou T., Gould A., Nussberger J., Waeber B., Brunner H.R., 1991. Clinical pharmacology and therapeutics, 50 (2) pp. 181-91. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_B2F2B38AFEF9]
 
Evaluation of arterial compliance-pressure curves. Effect of antihypertensive drugs.
Perret F., Mooser V., Hayoz D., Tardy Y., Meister J.J., Etienne J.D., Farine P.A., Marazzi A., Burnier M., Nussberger J. et al., 1991. Hypertension, 18 (4 Suppl) pp. II77-83. Peer-reviewed.
[WoS][Pmid][serval:BIB_94E703433F43]
 
Official standarts and recommendations: a critical comment
Waeber B., Hayoz D., Burnier M., Nussberger J., Brunner H. R., 1991. pp. 371-379 dans E. T. O'Brien , K. O'Malley (eds.) Handbook of Hypertension, Elsevier.
[serval:BIB_C13CEB899BCB]
1990
 
Ambulatory blood pressure monitoring and cardiovascular risk
Burnier M., Waeber B., Nussberger J., Brunner H. R., 1990. pp. 42-53 dans F. R. Buhler , J. H. Laragh (eds.) Handbook of Hypertension, Elsevier Science Publishers.
[serval:BIB_796FB97D25AC]
 
Characterization and Use of Four Anti-NPY Monoclonal Antibodies to Study NPY-Receptor Interaction
Grouzmann E, Walker P, Bohoun C, Burnier M, Comoy E, Brunner HR, Waeber B, 1990. Annals of the New York Academy of Sciences, 611 pp. 397-398. Peer-reviewed.
[DOI][WoS][serval:BIB_FF32D2AAEF08]
 
Comparative cardiovascular effects of drugs used for hypertension.
Burnier M., Waeber B., Nussberger J., Brunner H.R., 1990. Drugs, 39 Suppl 1 pp. 32-8. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_BE51FE907696]
 
Determination of plasma catecholamine and vasoactive peptide concentrations: clinical usefulness.
Waeber B., Nussberger J., Grouzmann E., Burnier M., Brunner H.R., 1990. International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology, 17 (7) pp. 667-72.
[Pmid][serval:BIB_B59262D90628]
 
Reactive hyperreninemia is a major determinant of plasma angiotensin II during ACE inhibition.
Mooser V., Nussberger J., Juillerat L., Burnier M., Waeber B., Bidiville J., Pauly N., Brunner H.R., 1990. Journal of cardiovascular pharmacology, 15 (2) pp. 276-82. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_4FAC08475B72]
 
Role of atrial natriuretic peptides and neuropeptide Y in blood pressure regulation.
Waeber B., Burnier M., Nussberger J., Brunner H.R., 1990. Hormone research, 34 (3-4) pp. 161-5. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_94187F66DA86]
 
Treating the individual hypertensive patient: considerations on dose, sequential monotherapy and drug combinations.
Brunner H.R., Ménard J., Waeber B., Burnier M., Biollaz J., Nussberger J., Bellet M., 1990. Journal of hypertension, 8 (1) pp. 3-11; discussion 13-9. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_ACC316ED4748]
 
Trials using a crossover design and ambulatory blood pressure recordings to determine the efficacy of antihypertensive agents in individual patients.
Waeber B., Burnier M., Nussberger J., Brunner H.R., 1990. Journal of hypertension. Supplement, 8 (4) pp. S37-41.
[WoS][Pmid][serval:BIB_FA3DC999C7E8]
 
Use of non-invasive ambulatory blood pressure monitoring to screen for high-risk hypertensive patients.
Christen Y., Ganslmayer M., Waeber B., Burnier M., Nussberger J., Brunner H.R., 1990. Journal of Hypertension. Supplement, 8 (6) pp. S119-124.
[WoS][Pmid][serval:BIB_58850C249582]
1989
 
Ambulatory blood pressure measurement and antihypertensive therapy.
Waeber B., Burnier M., Perret F., Nussberger J., Brunner H.R., 1989. Journal of hypertension. Supplement, 7 (3) pp. S33-39.
[WoS][Pmid][serval:BIB_03C91228DAFE]
 
Approche diagnostique du malade hypertendu [Diagnostic assessment of hypertensive patients]
Waeber B., Mooser V., Burnier M., Brunner H.R., 1989/01. Revue médicale de la Suisse romande, 109 (1) pp. 7-11.
[Pmid][serval:BIB_2079577A4404]
 
Bolus injections of synthetic atrial natriuretic peptide in patients with chronic renal failure or nephrotic syndrome.
Burnier M., Mooser V., Wauters J.P., Marder H.K., De Vane P., Nussberger J., Waeber B., Brunner H.R., 1989. Journal of cardiovascular pharmacology, 13 (5) pp. 682-90. Peer-reviewed.
[WoS][Pmid][serval:BIB_B5790B9E187C]
 
Clinical studies with atrial natriuretic peptides
Burnier M., Waeber B., Biollaz J., Nussberger J., Brunner H. R., 1989. pp. 169-183 dans B. M. Brenner , J. H. Laragh (eds.) Progress in Atrial Peptide Research., Raven press.
[serval:BIB_060078393E83]
 
Correlation between plasma concentration of cilazapril and haemodynamic and hormonal effects in healthy man.
Burnier M., Mooser V., Nussberger J., Waeber B., Brunner H.R., 1989. British journal of clinical pharmacology, 27 Suppl 2 pp. 189S-197S. Peer-reviewed.
[WoS][Pmid][serval:BIB_42FE91162326]
 
Effect of angiotensin converting enzyme inhibition in renovascular hypertension.
Burnier M., Waeber B., Nussberger J., Brunner H.R., 1989. Journal of Hypertension. Supplement, 7 (7) pp. S27-31.
[WoS][Pmid][serval:BIB_09A669FE1A27]
 
Effects of prolonged administration of the angiotensin converting enzyme inhibitor CGS 16617 in normotensive volunteers.
Waeber G., Burnier M., Porchet M., Nussberger J., Waeber B., Brunner H.R., 1989. European journal of clinical pharmacology, 36 (6) pp. 587-91. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_78D457293C1C]
 
Effects of smoking and physical exercise on platelet free cytosolic calcium in healthy normotensive volunteers.
Mooser V., Burnier M., Nussberger J., Juillerat L., Waeber B., Brunner H.R., 1989. Journal of hypertension, 7 (3) pp. 211-6. Peer-reviewed.
[WoS][Pmid][serval:BIB_4D9B0345E911]
 
Pharmacokinetics of angiotensin converting enzyme inhibitors.
Burnier M., Waeber B., Nussberger J., Brunner H.R., 1989. British journal of clinical pharmacology, 28 Suppl 2 pp. 133S-139S; discussion 140S. Peer-reviewed.
[WoS][Pmid][serval:BIB_15024170B46E]
1988
 
Individualization of antihypertensive therapy
Menard J., Brunner H. R., Waeber B., Plouin P. F., Burnier M., 1988/11. Hypertension, 12 (5) pp. 526-8.
[WoS][Pmid][serval:BIB_EAC93F97C1BD]
 
Effect of extracellular acidosis on 45Ca uptake in isolated hypoxic proximal tubules
Burnier M., Van Putten V. J., Schieppati A., Schrier R. W., 1988/06. American Journal of Physiology. Cell Physiology, 254 (6 Pt 1) pp. C839-46.
[WoS][Pmid][serval:BIB_E963A2045F52]
 
Cardiovascular effects of vascular antagoniste (VII) to the action of vasopressin in health and diseases
Burnier M., Waeber B., Nussberger J., Nicod P., Brunner H. R., 1988. pp. 473-479 dans A. W. Cowley , J. F. Liard , D. A. Ausiello (eds.) Nephrology, Proceedings of the Xth International Society of Nephrology, Raven Press.
[serval:BIB_4269C5EDAF1C]
 
Effect of vasopressin and alpha-adrenergic stimulation on platelet cytosolic free calcium.
Mooser V., Burnier M., Waeber B., Nussberger J., Juillerat L., Brunner H.R., 1988. Clinical and experimental hypertension. Part A., 10 pp. 936-942.
[serval:BIB_26D350D5E3DD]
 
Effects of a nonpressor dose of neuropeptide Y on cardiac output, regional blood flow distribution and plasma renin, vasopressin and catecholamine levels.
Aubert J.F., Burnier M., Waeber B., Nussberger J., Dipette D.J., Burris J.F., Brunner H.R., 1988. Journal of Pharmacology and Experimental Therapeutics, 244 (3) pp. 1109-1115. Peer-reviewed.
[WoS][Pmid][serval:BIB_DA3C8B44EDA7]
 
Effects of nonhypotensive endotoxemia in conscious rats: role of prostaglandins.
Burnier M., Waeber B., Aubert J.F., Nussberger J., Brunner H.R., 1988. American Journal of Physiology. Heart and Circulatory Physiology, 254 (3 Pt 2) pp. H509-H516.
[WoS][Pmid][serval:BIB_BE44CB67EEB5]
 
Endocrine response to heart failure
Burnier M., Waeber B., Nussberger J., Brunner H. R., 1988. pp. 74-89 dans C. Perret , J. L. Vincent (eds.) Update of Intensive Care and Emergency medicine: Acute Heart Failure, Springer Verlag.
[serval:BIB_127643618B52]
1987
 
Effet du facteur natriuretique auriculaire sur l'hematocrite de patients en hemodialyse chronique. [Effect of atrial natriuretic factor on the hematocrit of patients in chronic hemodialysis]
Burnier M., Porchet M., Waeber B., Wauters J. P., Brunner H. R., 1987/12. Schweizerische Medizinische Wochenschrift, 117 (49) pp. 1953-6.
[WoS][Pmid][serval:BIB_0488CA2C7172]
 
Acute renal failure. Managing a devastating illness
Spiegel D. M., Burnier M., Schrier R. W., 1987/09. Postgraduate Medicine, 82 (4) pp. 96-105.
[WoS][Pmid][serval:BIB_74A5B9ABC69D]
 
La fonction rénale sous inhibition de l'enzyme de conversion de l'angiotensine [Renal function after administration of angiotensin-converting enzyme inhibitors]
Waeber B., Burnier M., Nussberger J., Brunner H.R., 1987. Schweizerische medizinische Wochenschrift, 117 (37) pp. 1359-62. Peer-reviewed.
[WoS][Pmid][serval:BIB_218B1FF409E2]
 
Nicotine-induced release of vasopressin in the conscious rat: role of opioid peptides and hemodynamic effects.
Aubert J.F., Burnier M., Waeber B., Nussberger J., Brunner H.R., 1987. Journal of Pharmacology and Experimental Therapeutics, 243 (2) pp. 681-685. Peer-reviewed.
[WoS][Pmid][serval:BIB_10EDAE016B8B]
 
Prevention of Acute Renal Failure.
Burnier M., Schrier R. W., 1987. pp. 275-283 dans A. A. Amerio , P. Coratelli , V. M. Campese , S. G. Massry (eds.) Acute Renal Failure, Plenum Publishing Corporation.
[serval:BIB_1315E14720E9]
1986
 
Renal response to shock
Burke T. J., Burnier M., Langberg H., Shanley P., Schrier R. W., 1986/12. Annals of Emergency Medicine, 15 (12) pp. 1397-400.
[DOI][WoS][Pmid][serval:BIB_B34614CB2033]
 
Lithium infusion to study sodium handling in unanesthetized hypertensive rats
Biollaz J., Waeber B., Diezi J., Burnier M., Brunner H. R., 1986/02. Hypertension, 8 (2) pp. 117-21. Peer-reviewed.
[WoS][Pmid][serval:BIB_408F8470874C]
 
Idiopathic acute interstitial nephritis and uveitis in the adult. Report of 1 case and review of the literature
Burnier M., Jaeger P., Campiche M., Wauters J. P., 1986. American Journal of Nephrology, 6 (4) pp. 312-5.
[DOI][WoS][Pmid][serval:BIB_4469FAFD23CD]
1985
 
Does renal failure induce a decrease in cyclosporine blood concentrations?
Burnier M., Aebischer P., Wauters J. P., Schelling J. L., 1985. Proceedings of the European Dialysis and Transplant Association - European Renal Association, 21 pp. 1002-5.
[WoS][Pmid][serval:BIB_B742741C535E]
1983
 
Blood pressure maintenance in awake dehydrated rats: renin, vasopressin, and sympathetic activity
Burnier M., Biollaz J., Brunner D. B., Brunner H. R., 1983/08. American Journal of Physiology. Heart and Circulatory Physiology, 245 (2) pp. H203-9.
[WoS][Pmid][serval:BIB_98C3E458F2EF]
 
Plasma vasopressin in rats: effect of sodium, angiotensin, and catecholamines
Brunner D. B., Burnier M., Brunner H. R., 1983/02. American Journal of Physiology. Heart and Circulatory Physiology, 244 (2) pp. H259-65.
[WoS][Pmid][serval:BIB_92E3EBC09402]
 
Pressor responses of rats to vasopressin: effect of sodium, angiotensin, and catecholamines
Burnier M., Brunner H. R., 1983/02. American Journal of Physiology. Heart and Circulatory Physiology, 244 (2) pp. H253-8.
[WoS][Pmid][serval:BIB_A731341CD1D4]
 
Alpha and beta adrenoceptor blockade in normotensive and deoxycorticosterone (DOC)-hypertensive rats; plasma vasopressin and vasopressin pressor effect
Burnier M., Biollaz J., Brunner D. B., Gavras H., Brunner H. R., 1983/01. Journal of Pharmacology and Experimental Therapeutics, 224 (1) pp. 222-7.
[WoS][Pmid][serval:BIB_D165F3DEC373]
1982
 
Comparison in normal volunteers of three converting enzyme inhibitors: RHC 3659, MK 421 and captopril
Burnier M., Biollaz J., Brunner H. R., Turini G. A., Gavras H., 1982/04. American Journal of Cardiology, 49 (6) pp. 1550-1.
[DOI][WoS][Pmid][serval:BIB_D0D272885C4D]
1981
 
RHC 3659: a new orally active angiotensin converting enzyme inhibitor in normal volunteers
Burnier M., Turini G. A., Brunner H. R., Porchet M., Kruithof D., Vukovich R. A., Gavras H., 1981/12. British Journal of Clinical Pharmacology, 12 (6) pp. 893-9.
[WoS][Pmid][serval:BIB_504D3E5AF38C]
 
Three new long-acting converting-enzyme inhibitors: relationship between plasma converting-enzyme activity and response to angiotensin I
Biollaz J., Burnier M., Turini G. A., Brunner D. B., Porchet M., Gomez H. J., Jones K. H., Ferber F., Abrams W. B., Gavras H. et al., 1981/05. Clinical Pharmacology and Therapeutics, 29 (5) pp. 665-70.
[DOI][WoS][Pmid][serval:BIB_D12B06E58ADA]
Partagez:
Unicentre - CH-1015 Lausanne
Suisse
Tél. +41 21 692 11 11
Canton de Vaud
Swiss University